Of 93 patients randomized to azacitidine maintenance, 87 started the treatment. The plan was to complete 12 cycles of maintenance treatment for patients randomized to azacitidine maintenance. Patients randomized to the control arm (n = 94) did not receive any intervention. allo-SCT, allogeneic stem cell transplantation; CMML, chronic myelomonocytic leukemia.